UC News

#cipla#

Cipla gets EIR for Bommasandra API plant

Business Standard

Paras Adenwala's Outlook On Cipla Q3 Numbers | NSE Closing Bell

CNBC-TV18

Cipla Reports Higher Q2 Earnings On YoY Basis | YOUR STOCKS

CNBC-TV18

Cipla Gets Final Nod from USFDA for Migraine Treatment Nasal Spray

Latestly

Stocks in news: Cipla, Maruti Suzuki and Bank of India

The Economic Times

Market Pulse- Cipla Plans Open Access To HIV Drug Patent

Bloomberg TV India

Cipla On USFDA Radar Again, Surprise Inspection Underway At Indore

ET NOW

Cipla inks licensing pact with Gilead Sciences for potential COVID-19 treatment drug Remdesivir

Deccan Herald

Jubilant Life, Cipla rally up to 6% on inking pact with Gilead Sciences

Business Standard

ICICI Bank, RIL, Cipla in focus

Business Standard

Cipla, Biocon, Unichem Labs at centrestage

Business Standard

In Business: EBIDTA Margin Target Of 21% For The Year: Cipla

Bloomberg TV India

Cipla Reports Q3 Earnings In Pink Of Health | Bazaar Corporate Radar

CNBC-TV18

COVID-19 treatment: Gilead gives royalty-free licences for remdesivir to India’s Jubilant, Cipla, 3 others

The Statesman

Market Headstart | Nifty seen opening positive; L&T Infotech, Cipla top buys

Moneycontrol

Cipla, Lupin Q3 Results Today: Key Things To Watch Out For

CNBC-TV18

Cipla Receives Warning Letter From US FDA, Shares Fall | Trading Hour

CNBC-TV18

Earnings Edge- Sun Pharma Q2 Profits Rise, While Cipla Misses Est

Bloomberg TV India

Cipla Receives Warning Letter From USFDA, Shares Fall | Bazaar Open Exchange

CNBC-TV18

US FDA Issues 'Warning Letter' To Cipla's Goa Unit | Business Lunch

CNBC-TV18